Gedik H - Search Results

1

Which Multidrug-Resitant Bacteria are Emerging in Patients with Hematological Malignancies?: One-Year Report.

Gedik H, Şimşek F, Yıldırmak T, Kantürk A, Aydın D, Demirel N, Yokuş O, Arıca D. Gedik H, et al. Indian J Hematol Blood Transfus. 2015 Mar;31(1):51-6. doi: 10.1007/s12288-014-0402-4. Epub 2014 May 14. Indian J Hematol Blood Transfus. 2015. PMID: 25548445 Free PMC article.

2

Pulmonary involvement of Brucellosis: a report of six cases.

Simsek F, Yildirmak MT, Gedik H, Kantürk A, Iris EN. Simsek F, et al. Among authors: gedik h. Afr Health Sci. 2011 Aug;11 Suppl 1(Suppl 1):S112-6. doi: 10.4314/ahs.v11i3.70080. Afr Health Sci. 2011. PMID: 22135635 Free PMC article.

3

Does antimicrobial use increase the rate of antimicrobial resistance? A one year experience.

Gedik H. Gedik H. Indian J Med Microbiol. 2012 Apr-Jun;30(2):198-202. doi: 10.4103/0255-0857.96692. Indian J Med Microbiol. 2012. PMID: 22664437 Free article.

4

[A case of persistent urinary schistosomiasis transmitted through Lake Malawi].

Yıldırmak MT, Simşek F, Gedik H, Kantürk A. Yıldırmak MT, et al. Among authors: gedik h. Turkiye Parazitol Derg. 2012;36(3):191-2. doi: 10.5152/tpd.2012.46. Turkiye Parazitol Derg. 2012. PMID: 23169168 Free article. Turkish.

5

Colistin against colistin-only-susceptible Acinetobacter baumannii-related infections: Monotherapy or combination therapy?

Simsek F, Gedik H, Yildirmak MT, Iris NE, Türkmen A, Ersoy A, Ersöz M, Gücüyener A. Simsek F, et al. Among authors: gedik h. Indian J Med Microbiol. 2012 Oct-Dec;30(4):448-52. doi: 10.4103/0255-0857.103767. Indian J Med Microbiol. 2012. PMID: 23183471 Free article.

6

Fungal pathogens and primary antifungal prophylaxis in patients with hematological malignancies: one year experience.

Gedik H, Yildirmak MT, Simsek F, Aydin D, Demirel N, Yokus O, Arica D. Gedik H, et al. Afr Health Sci. 2012 Sep;12(3):390-4. doi: 10.4314/ahs.v12i3.23. Afr Health Sci. 2012. PMID: 23382758 Free PMC article.

7

Tuberculous meningitis: a report of 60 adult cases.

Ersöz M, Yildirmak MT, Gedik H, Simşek F, Kantürk A, Iris NE, Dinç E. Ersöz M, et al. Among authors: gedik h. West Indian Med J. 2012 Sep;61(6):592-7. West Indian Med J. 2012. PMID: 23441353

8

The outcome of non-carbapenem-based empirical antibacterial therapy and VRE colonisation in patients with hematological malignancies.

Gedik H, Yildirmak T, Simsek F, Kanturk A, Aydýn D, Anca D, Yokus O, Demirel N. Gedik H, et al. Afr Health Sci. 2013 Jun;13(2):362-8. doi: 10.4314/ahs.v13i2.24. Afr Health Sci. 2013. PMID: 24235937 Free PMC article.

9

Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage.

Gedik H, Simşek F, Yıldırmak T, Kantürk A, Arıca D, Aydın D, Demirel N, Yokuş O. Gedik H, et al. Ther Clin Risk Manag. 2014 Apr 28;10:305-12. doi: 10.2147/TCRM.S59683. eCollection 2014. Ther Clin Risk Manag. 2014. PMID: 24855365 Free PMC article.

10

Is Timely and Appropriate Antifungal Drug Enough for Survival of Adult Cases with Candidaemia? Five-year Experience.

Yildirmak MT, Gedik H, Simsek F, Iris NE, Gücüyener A. Yildirmak MT, et al. Among authors: gedik h. West Indian Med J. 2013 Nov;62(8):724-30. doi: 10.7727/wimj.2012.140. West Indian Med J. 2013. PMID: 25014858

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters